EMA Grants Accelerated Assessment for CSL Behring's Haemophi

MARBURG, Germany, Dec. 15, 2021 /PRNewswire/ -- CSL Behring today announced that the European Medicines Agency (EMA) has granted its approval for an accelerated assessment request for etranacogene

Related Keywords

Germany , Australia , United States , Melbourne , Victoria , Frankfurt , Brandenburg , Vita Cslbehring , Wolfgang Miesbach , Karen Pinachyan , Faraz Kermani , Etranacogene Dezaparvovec , Head Of Medical Affairs Europe , University Hospital Of Frankfurt , Twitter , European Union , European Medicines Agency , Drug Administration , Marketing Authorisation Application , Breakthrough Therapy Designation , United States Food , Priority Medicine , Lutz Bonacker Senior Vice President , General Manager Europe , Medical Affairs Europe , Prof Wolfgang Miesbach , University Hospital , Gene Therapy , Migrants , Ccelerated , Assessment , Gehring , Haemophilia , Gene , Therapy ,